Aeterna Zentaris Inc. (NASDAQ:AEZS) belongs to Healthcare sector. Its weekly performance is -12.43%. On last trading day company shares ended up $0.24. Aeterna Zentaris Inc. (NASDAQ:AEZS) distance from 50-day simple moving average (SMA50) is -30.61%. On 30 June, Aeterna Zentaris Inc. (NASDAQ:AEZS) announced it has reached its goal of recruiting 500 patients for its pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) clinical study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer. The trial is being conducted in over 120 sites in North America, Europe and Israel. The primary efficacy endpoint is improvement in overall survival.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shares moved up 1.77% in last trading session and ended the day at $8.64. BDSI Gross Margin is 83.10% and its return on assets is -61.40%. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) quarterly performance is -9.05%.
On 10 July, Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) shares increased 9.03% and was closed at $0.99. YGE EPS growth in last 5 year was -14.30%. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) year to date (YTD) performance is -57.78%. Yingli Green Energy Holding Company Limited (NYSE:YGE) announced that its wholly-owned subsidiary, Yingli Green Energy Singapore Company Pte. Limited (“Yingli Singapore”), has provided 4 kilowatts (kW) of solar panels to energize a school and a health clinic in rural Laos. Each site is equipped with a 2 kW off-grid system that is now operational, and provides its occupants with access to electricity for the first time. The school is located in Phongasavang and the health clinic is located in Lad Khammune.
Acuity Brands, Inc. (NYSE:AYI) ended the last trading day at $191.43. Company weekly volatility is calculated as 1.61% and price to cash ratio as 12.78. Acuity Brands, Inc. (NYSE:AYI) showed a weekly performance of 1.29%. Acuity Brands (NYSE: AYI) reported Q3 EPS of $1.37, $0.03 better than the analyst estimate of $1.34. Revenue for the quarter came in at $683.7 million versus the consensus estimate of $686.94 million.
Exar Corp. (NYSE:EXAR) shares moved up 2.43% in last trading session and ended the day at $9.26. EXAR Gross Margin is 40.70% and its return on assets is -14.10%. Exar Corp. (NYSE:EXAR) quarterly performance is -12.56%. On 6 July, Exar Corporation (NYSE:EXAR), introduces a highly integrated sensor interface analog front end (AFE) that provides calibration of sensor outputs. The XR10910 offers an onboard 16:1 differential multiplexer, offset correction DAC, programmable gain instrumentation amplifier and voltage reference. This AFE provides 14-bit signal path linearity and is designed to connect multiple bridge sensors to a microcontroller (MCU) or field-programmable gate array (FPGA) with an embedded ADC.